Diagnos Laboratorium Utama Tbk. vs Trimuda Nuansa Citra Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Trimuda Nuansa Citra Tbk. trades at Rp134 (market cap 57.76B, 4.46M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 5.4× Trimuda Nuansa Citra Tbk.'s market cap, and Trimuda Nuansa Citra Tbk. is more actively traded (4.46M versus 963.6K). Which is the better fit depends on your goals.
| DGNS | TNCA | |
|---|---|---|
Market Cap | 310.75B | 57.76B |
Volume | 963.6K | 4.46M |
Lot | 9.64K | 44.55K |
Turnover | 217.67M | 588.72M |
Average Price | 225.89 | 132.15 |
Value | 217.67M | 588.72M |
Indicative Equilibrium Price | 226 | 134 |
Indicative Equilibrium Volume | 1K | 183 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Trimuda Nuansa Citra Tbk(the Company) was established in Indonesia in accordance with Deed of Establishment of Limited Liability Company Company No. 21 dated May 4, 1995 made before H. Asmawel Amin, S.H., Notary in Jakarta.
Read more on TNCA →